Back
Viking Therapeutics Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
24
VKTX
Viking Therapeutics
Last Price:
$42.71
Seasonality Move:
21.99%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
Viking Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.46 | Sell |
| 20-day SMA: | 47.87 | Sell |
| 50-day SMA: | 56.89 | Sell |
| 200-day SMA: | 61.45 | Sell |
| 8-day EMA: | 43.58 | Sell |
| 20-day EMA: | 47.31 | Sell |
| 50-day EMA: | 53.29 | Sell |
| 200-day EMA: | 54.12 | Sell |
Viking Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.05 | Sell |
| Relative Strength Index (14 RSI): | 34.2 | Sell |
| Chaikin Money Flow: | 146451 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.46 - 52.88) | Sell |
| Bollinger Bands (100): | (50.86 - 67.3) | Sell |
Viking Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 42.35 while VKTX 8-day simple moving average is 43.46, which is a Sell signal.
-
The stock price of VKTX is 42.35 while Viking Therapeutics 20-day SMA is 47.87, which makes it a Sell.
-
Viking Therapeutics 50-day simple moving average is 56.89 while VKTX share price is 42.35, making it a Sell technically.
-
VKTX stock price is 42.35 and Viking Therapeutics 200-day simple moving average is 61.45, creating a Sell signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
24
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a SellThe current Viking Therapeutics [VKTX] share price is $42.35. The Score for VKTX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics Stock Info
Market Cap:
4.7B
Price in USD:
42.35
Share Volume:
1.1M
Viking Therapeutics 52-Week Range
52-Week High:
99.41
52-Week Low:
17.23
Sell
24
Viking Therapeutics (VKTX)
is a Sell
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?The Viking Therapeutics stock price is 42.35 USD today.
-
Will VKTX stock go up or go down?Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Viking Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is overvalued.
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 42.35 while VKTX 8-day exponential moving average is 43.58, which is a Sell signal.
-
The stock price of VKTX is 42.35 while Viking Therapeutics 20-day EMA is 47.31, which makes it a Sell.
-
Viking Therapeutics 50-day exponential moving average is 53.29 while VKTX share price is 42.35, making it a Sell technically.
-
VKTX stock price is 42.35 and Viking Therapeutics 200-day simple moving average is 54.12, creating a Sell signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
-
VKTX Moving Average Covergence Divergence (MACD) indicator is -4.05, suggesting Viking Therapeutics is a Sell
-
Viking Therapeutics Relative Strength Index (RSI) is 34.2, which suggest Viking Therapeutics is oversold
-
The Bollinger Bands (25) for Viking Therapeutics is (44.46 - 52.88), which suggest Viking Therapeutics is a Sell
-
The Bollinger Bands (100) for Viking Therapeutics is (50.86 - 67.3), which suggest Viking Therapeutics is a Sell
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.